News
Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
FDA issues Guidance for Industry on submissions for HLA testing kitsFDA issues final guidance on the design and analysis of shedding studiesHTA provides statement on regulation of blood as a starting material for ATMPsHTA announces workshops on updated codes of practiceEMA releases addendum to ICH E6 guideline on good clinical practiceUK Cell Therapy GMP Manufacturing Capacity and Capability IncreasesCollaboration to Improve Viral Vector Industrialisation ProcessCell Therapy Catapult Awards Major Contract to Cellular Therapeutics Limited to Accelerate WT1 Clinical ProgrammeCAT publishes Monthly Report for July 2015EMA publishes new draft guidance on fast track routes to marketing authorisationEMA announces workshop on facilitating the development of advanced therapies in September 2015Early dialogue to support development of medicines for children